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Background: The present study was undertaken to evaluate the antihyperglycemic, antihyperlipidemic and
hepatoprotective effect of a traditional unani formulation “Qurs Tabasheer” in streptozotocin (STZ) induced diabetic
wistar rats. Up till now no study was undertaken to appraise the efficacy of “Qurs Tabasheer” in the diabetic rats.
Qurs Tabasheer is a unani formulation restraining preparations from five various herbs namely Tukhme Khurfa
(Portulaca oleracea seed), Gule Surkh (Rosa damascena flower), Gulnar (Punica granatum flower), Tabasheer (Bambusa
arundinasia dried exudate on node), Tukhme Kahu (Lactuca sativa Linn seed).
Methods: Effect of Qurs Tabasheer was assessed in STZ (60 mg/kg, i.p single shot) induced diabetic wistar rats. STZ
produced a marked increase in the serum glucose, Total Cholesterol, LDL cholesterol, VLDL Cholesterol,
Triglycerides and trim down the HDL level. We have weighed up the effect of Qurs Tabasheer on hepatic activity
through estimating levels of various liver enzymes viz. Hexokinase, Glucose-6-Phosphatase and Fructose-1-6-
biphosphatase in STZ diabetic wistar rats.
Results: In STZ-induced diabetic wistar rats level of Hexokinase, and Glucose-6-Phosphatase was decreased to a
significant level while the level of fructose-1-6-biphophatase was augmented. Therapy with Qurs Tabasheer for
28 days to STZ-induced diabetic rats significantly reduces the level of serum glucose, total cholesterol, triglycerides,
glucose-6-phosphatase and fructose-1-6-biphosphatase, while magnitude of HDL cholesterol and hexokinase was
amplified.
Conclusion: Antihyperglycemic, antihyperlipidemic activity of Qurs Tabasheer extract in STZ- induced wistar rats
was found to be more effective than standard oral hypoglycemic drug Glimepiride.
Keywords: Diabetes mellitus, Hepatoprotective, Hyperlipidemia, Polyherbal, Qurs Tabasheer, Unani formulationBackground
Diabetes mellitus is rapidly reaching epidemic proportions
in many areas of the world. According to WHO an esti-
mated 80 million people in India will suffer from diabetes
by the year 2030 [1]. The purported Indian Phenotype
proposed to have inimitable biochemical as well as clinical
idiosyncrasy in the Indians of Asia. This assemblage of* Correspondence: danish.ahmed@shiats.edu.in
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reproduction in any medium, provided the orabnormalities is well thought-out to be one of the fore-
most factors contributing to raise pervasiveness of type 2
diabetes in Indians of Asia.
Diabetes mellitus is linked with prejudice glucose me-
tabolism that escorts to a rise in free radical production
and augmentation in the lipoprotein and triglyceride
levels. Experimental diabetes in animals has endowed
with extensive approach into the physiologic and bio-
chemical clutter of the diabetic state. Many of the dis-
order have been characterized in hyperglycemic animals.
Significant changes in lipid metabolism also crop up in
diabetes [2]. Deregulation of hepatic enzymes such asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sphatase occurs in diabetic rats [3,4].
Alternative and traditional medicines have scores of
advantages over the conventional medicines. Despite many
conventional therapies are present in the market to curtail
the diabetes and its complications, traditional medicines
such as Unani formulations has unambiguous advantage of
being almost free from adverse effects. Diversity, flexibility,
easy accessibility, broad continuing acceptance in develop-
ing countries and increasing popularity in developed coun-
tries, relative low cost, low levels of technological input,
relative low side effects and growing economic importance
are some of the positive features of traditional medicine
(WHO 2002).
Polyherbal formulations more willingly than mono-
therapeutic herbal formulation are frequently used be-
cause of the synergistic effect. Many polyherbal
formulation such as Okudiabet [5] Diashis [6], Diasulin
[7] etc. have revealed their efficacy and potency against
diabetes.
Qurs Tabasheer is composed of 5 (five) medicinal
plants (Table 1). Till now no research has been reported
on Qurs Tabasheer’s hypoglycemic, antihyperlipidemic
and hepatoprotective activity on STZ- induced diabetic
rats. The present exploration was undertaken to study
the effect of Qurs Tabasheer, a polyherbal unani formu-
lation on alterations in plasma glucose, glycated heamo-
globin (A1c), total cholesterol, triglycerides, hexokinase,
glucose-6-phosphatase, fructose-1-6-biphosphatase along
with weight variation in STZ-induced diabetic wistar
rats. The results obtained from Qurs Tabasheer were
weighed against standard drug Glimepiride.Criteria for selection of herbs
In order to support and to select the preeminent com-
position/ratio of the five herbs: Tukhme Khurfa (Portu-
laca oleracea seed), Gule Surkh (Rosa damascena
flower), Gulnar (Punica granatum flower), Tabasheer
(Bambusa arundinasia dried exudate on node), Tukhme
Kahu (Lactuca sativa Linn seed utilized to prepare Qurs
Tabasheer, a polyherbal formulation, we have executed
the in-vitro antidiabetic assays with the various selected
doses of the polyherbal formulation:Table 1 Qurs Tabasheer (Composition & concentration)
S.No. Botanical name Hindi name (common name)
1 Portulaca oleracea Tukhme Khurfa
2 Rosa damascena Gule Surkh
3 Punica granatum Gulnar
4 Bambusa arundinacea Tabasheer
5 Lactuca sativa Linn Tukhme Kahu
*Stock sample used in the experiment.α – amylase inhibition assay
The α-amylase inhibition assay was carried out according
to the procedure reported by Subashini Devarajan et al.
[13]. Each test tube containing 500 μL of concentrations of
Portulaca Oleracea (100 mg.kg-1 L-1, 200 mg kg-1 L-1,
300 mg kg-1 L-1, 400 mg kg-1 L-1, 500 mg kg-1 L-1), Rosa
damascena(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1), Punica granatum
(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1), Bambusa arundinacea
(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1) and Lactuca sativa
Linn(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-,
400 mg kg-1 L-1,500 mg kg-1 L-1of methanol) of Polyher-
bal formulation and 500 μL of 0.02 mol.L-1 sodium
phosphate buffer (pH 6.9 with 0.006 mol.L-1 NaCl)
containing α- amylase solution (0.5 mg. mL-1) were
incubated for 10 min at 25°C. After pre-incubation,
500 μL of 1% starch solution in 0.02 mol.L-1 sodium
phosphate buffer (pH 6.9 with 0.006 mol.L-1 NaCl)
was added to each tube. The reaction mixtures were
then incubated at 25°C for 10 min. The reaction was
stopped with 1.0 mL of dinitrosalicylic acid color re-
agent. The test tubes were then incubated in a boil-
ing water bath for 5 min and cooled to room
temperature. The reaction mixture was then diluted
after adding 10 mL of distilled water and absorbance
was measured at 540 nm; α-amylase inhibition assay
was calculated using the formula:
%ð Þ ¼ A540control A540extractð Þ=A540control½ 
 100
Natural α -amylase inhibitors from herbal sources offer
an attractive therapeutic approach to the treatment of post-
prandial hyperglycemia by decreasing glucose release from
starch and have potential for the treatment of diabetes mel-
litus and obesity [14,15]. The inhibitory activity of metha-
nolic extract of various ingredients of Qurs Tabasheer
against pancreatic amylase is shown in Table 2. As evident
from the results shown in Table 2, the maximum inhibition
of α – amylase has been achieved at 500 mg/kg L-1 of each
constituent. Concentration dependent inhibitory activity of
α – amylase was observed at 100, 200, 300, 400, 500Family Part used Composition* (%)
Portulacaceae Seed 10 ≈ (500 mg/kg) [8]
Rosaceae Flower 10 ≈ (500 mg/kg) [9]
Lythraceae Flower 10 ≈ (500 mg/kg) [10]
Poaceae Dried exudate on node) 50 ≈ (500 mg/kg) [11]
Asteraceae Seed 10 ≈ (500 mg/kg) [12]
Table 2 α – amylase inhibition of methanolic extracts of various ingredients of Qurs Tabasheer (±SE, n = 3)































1 100 37.41 ± 0.58 100 28.81 ± 0.61 100 34.82 ± 0.28 100 38.09 ± 0.72 100 32.81 ± 0.96
2 200 41.82 ± 1.83 200 44.76 ±0.92 200 40.03 ±1.61 200 45.18 ±0.51 200 49.58 ±0.59
3 300 68.38 ±2.81 300 52.92 ±1.29 300 60.18 ±0.69 300 68.71 ±1.59 300 66.75 ±1.61
4 400 71.19 ±1.97 400 67.71 ±1.58 400 69.71 ±0.21 400 74.49 ±2.57 400 76.07 ±1.97
5 500 79.09 ±0.82 500 72.82 ± 1.09 500 76.70 ±1.08 500 93.59 ±1.88 500 81.10 ±0.48
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concentration according to the propensity to inhibit α –
amylase. Results are expressed as the percentage sample
absorbance decrease relative to the absorbance of control
solution in the absence of extract ingredients at 540 nm.α – glucosidase inhibition assay
α – glucosidase inhibition assay was performed accord-
ing to Dong et al. [16]. The inhibitory activity was
determined by incubating a volume of 60 μL of each
of sample solution containing Portulaca Oleracea
(100 mg.kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1), Rosa damascena
(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1), Punica granatum
(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1), Bambusa arundina-
cea (100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-1,
400 mg kg-1 L-1, 500 mg kg-1 L-1) and Lactuca sativa
Linn(100 mg kg-1 L-1, 200 mg kg-1 L-1, 300 mg kg-1 L-,
400 mg kg-1 L-1,500 mg kg-1 L-1of methanol and 50 μL
of 0.1 M phosphate buffer (pH 6.8) containing α –
glucosidase solution (0.2 U/ml) was incubated in 96
well plates at 37°C for 10 min. After pre-incubation,
50 μL of 5 mM p-nitrophenyl-a-D-glucopyranoside
(PNPG) solution in 0.1 M phosphate buffer (pH 6.8)
was added to each well and incubated at 37°C for
another 20 min. Then the reaction was stopped byTable 3 α – glucosidase inhibition of methanolic extracts of v


















1 100 15 ± 1.61 100 17 ± 0.85 100
2 200 26 ± 0.51 200 24 ±1.42 200
3 300 38 ±1.84 300 31 ±2.66 300
4 400 51 ±2.77 400 50 ±0.87 400
5 500 67 ±0.19 500 61 ± 1.82 500adding 160 μL of 0.2 M NaCO3 into each well, and
absorbance readings (A) were recorded at 405 nm. α –
glucosidase inhibitory activity was expressed as inhib-
ition % and was calculated as follows:
Inhibition % ¼ Acontrol  Asample
 
=Acontrol x 100
Therefore, as it is evident from the above Table 3 exhi-
biting the α – amylase and α – glucosidase inhibition.
The maximum percentage inhibition in both the cases
was achieved by the extract of Bambusa arundinacea in-
gredient of Qurs Tabasheer. For this reason, we have
selected the 50% composition of Bambusa arundinacea
as compared to the others in order to maximize the gly-
cemic control in STZ-diabetic rats.
Accelerated stability testing of qurs tabasheer
Herbal preparations are thought to be degraded if stored
for a longer period of time. Therefore, we have per-
formed accelerated stability testing of the Qurs Tabash-
eer, a polyherbal formulation. To establish the stability
of the Qurs Tabasheer, we have prepared five samples of
polyherbal formulation and the parameters like pH, Vis-
cosity, Refractive Index (R.I), Surface tension, Specific
gravity and microbiological load was assessed at an
interval of 0, 24, 48, 72, 96 and 120 Hrs, maintaining the
packs of formulations at 30 ± 2°C and at 65% Relative
humidity [17].arious ingredients of Qurs Tabasheer (±SE, n = 3)




















12 ± 1.66 100 19 ± 1.72 100 14 ± 2.98
29 ±0.96 200 21 ±1.61 200 19 ±0.77
34 ±1.07 300 29 ±1.53 300 26 ±1.90
56 ±1.95 400 48 ±1.43 400 41 ±0.18
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interval of 0, 24, 48, 72, 96 and 120 Hrs was determined
using pH meter (Orion digital pH meter).
2.Determination of Viscosity: Ostwald viscometer
(Sigma Aldrich, M.O. USA) was used to determine
the viscosity of all the samples of Qurs Tabasheer at
an interval of 0, 24, 48, 72, 96 and 120 Hrs.
3.Determination of Refractive Index (R.I): Abee’s
refractometer (Cole-Parmer, India) was used to
determine the refractive index of the formulation at
an interval of 0, 24, 48, 72, 96 and 120 Hrs. as per
the procedure.
4.Determination of Surface Tension: The samples of
Qurs Tabasheer were assessed by Stalagmometer
(Kocour, US) at an interval of 0, 24, 48, 72, 96 and
120 Hrs.
5.Determination of Specific Gravity: All the samples of
Qurs Tabasheer were determined by using
Pycnometer (Chemkind, India) at an interval of 0, 24,
48, 72, 96 and 120 Hrs.
6.Microbiological Load: Bioburden level [18,19] The
basis of Bioburden level is the determination of
microbial contamination limits in medicinal plant
materials. It indicates the quality of an herbal
formulation. The total viable aerobic count of the
polyherbal formulation being examined by
utilizing plate count method. Polyherbal
formulation, Qurs Tabasheer after treatment with
sodium chloride-peptone buffer solution (pH = 7.0)








Colour Greenish Greenish Gr
Odor Pleasant Pleasant Pl
External Appearance Clear Liquid Clear Liquid Clea
pH 4.1 4.1
Viscosity 1.02 1.04
Surface Tension 110.26 112.71 1
Specific Gravity 1.51 1.49
Refractive Index (RI) 1.429 1.448
Microbiological Load (Bioburden level)
1 Total Aerobic plate count 4900 CFU/g 4891 CFU/g 474
2 E.coli Absent Absent A
3 Salmonella Absent Absent A
4 S. aureus Absent Absent A
5 Klebsiella Absent Absent A
6 Clostridium botulinum Absent Absent A
U = Colony Forming Unit.agar. The samples were incubated at 30-35°C at
an interval of 0, 24, 48, 72, 96 and 120 Hrs. The
numbers of colonies formed were counted after
the specified time interval.
It is apparent from the Table 4 that accelerated stabil-
ity data follows a linear pattern throughout the stability
testing. Physical parameters such as color, odor etc. does
not produce significant changes. Furthermore, the harm-
ful microorganism were absent throughout the acceler-
ated stability studies. The above stability studies indicate
that Qurs Tabasheer is stable at room temperature for
quite a longer period of time. However, real time stabil-
ity studies are underway to confirm these findings.Methods
Preparation of qurs tabasheer extract
The five medicinal plants stated above were obtained from
different sources viz. Bio India Biologicals (BIB) Corpor-
ation, Hyderabad, India, Green Earth Products Pvt. Ltd.
New Delhi, India, & Raj Hans Products, Mumbai, India.
The plants were confirmed by experts from Department
of Botany, Sam Higginbottom Institute of Agriculture,
Technology & Sciences. The preferred parts of the five
medicinal plants were kept and dried in an incubator for
about 24 hours at 37°C. The dried parts were then crushed
and minced in the ratio specified in Table 1. This polyher-
bal formulation was prepared according to the procedure
specified by Pandy et al. [20].Qurs Tabasheer










eenish Greenish Greenish Greenish
easant Pleasant Pleasant Pleasant
r Liquid Clear Liquid Clear Liquid Clear Liquid
4.2 4.2 4.3 4.2 4.18 ± 0.72
1.02 1.07 1.05 1.03 1.038 ± 1.07
12.09 114.83 111.05 113.29 112.37 ± 0.28
1.50 1.43 1.58 1.54 1.508 ± 1.70
1.584 1.461 1.502 1.490 1.485 ± 0.69
0 CFU/g 4684 CFU/g 4591 CFU/g 4410 CFU/g 4702 ± 2.05
bsent Absent Absent Absent
bsent Absent Absent Absent
bsent Absent Absent Absent
bsent Absent Absent Absent
bsent Absent Absent Absent
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Streptozotocin solution was prepared by dissolution in
0.1 M citrate buffer (pH = 4.5).
Streptozotocin (STZ) was procured from Sisco Research
Laboratory, Pvt. Ltd. Mumbai, India. Glimepiride was gen-
erous gift from Ranbaxy Laboratories, Gurgaon, India.
Chemical including ethyl alcohol, trichloro acetic acid, di-
ethyl ether, and citric acid was purchased from CDH,
Mumabi, India. All other chemicals and bioassay kits were
purchased from Sigma Chemical Company Inc. (St. Louis,
MO, USA) and Span Diagnostics, Surat, India.
Animals
Male Wistar rats, weighing between 190-230 g, were
selected. All animals were provided with standard pellets
and drinking water ad libitum. All experiments and proto-
cols described in the current study are in accordance with
guidelines of Committee for the Purpose of Control and
Supervision on Experiments on Animals (CPCSEA). This
study has been duly approved by the IAEC (Institutional
Animal Ethical Committee, Jamia Hamdard) and CPCSEA.
Water used for the solution preparation and glassware
washing was passed through an Easy Pure UF water purifi-
cation unit (Thermolyne Barnstead, NH, USA).
Induction of diabetes
Wistar rats were injected intraperitoneally with STZ dis-
solved in 0.1 M citrate buffer (pH = 6.5) at 60 mg/kg.
Animals of control group were received equal volume of
vehicle. After 48 hours of STZ injection, blood glucose
of the induced rats was estimated. The rats depicting
FBG ≥ 230 mg/dL considered to be diabetic.
Statistical analysis
Data was put across as the mean ± SEM. For statistical
analysis of the data, group means were compared by one-
way analysis of variance (ANOVA) followed by Dunnett’s
‘t’ test, which was used to identify difference between
groups. P value <0.05 was considered significant.
Experimental design
In our experiment, rats were randomized into six groups
comprising of five animals each group as discussed
below:
Group I. Normal control rats received citrate buffer
(pH = 4.5) for 28 days. (1 mL/kg p.o.)
Group II. Normal control rats received Qurs Tabasheer
(200 mg/kg p.o.) and continued for 28 days
Group III. STZ-diabetic rats received STZ
(intraperitoneally, 60 mg/kg, single shot)
Group IV. Qurs Tabasheer treated diabetic rats received
Qurs Tabasheer (50 mg/kg p.o.) and
continued for 28 days.Group V. Qurs Tabasheer treated diabetic rat received
Qurs Tabasheer (100 mg/kg p.o) and
continued for 28 days.
Group VI. Qurs Tabasheer treated diabetic rat received
Qurs Tabasheer (200 mg/kg p.o) and
continued for 28 days.
Group VII. Glimepiride treated diabetic rats received
Glimepiride (1 mg/kg p.o.) and continued
for 28 days.
Drug was given to the rats with the help of oral cath-
eter every morning. At the finish of the drug treatment
all the animals was faster overnight but allow free access
to water. Rats were divided into the above seven groups
for 28 days of study. The duration of drug treatment was
set to be 28 days for the reason that 28 days were the
threshold in our pilot experiments.
Results
To evaluate the effect of Qurs Tabasheer on STZ-
induced diabetes mellitus rats, several biochemical esti-
mations were carried out in all groups of experimentally
induced diabetes rats for the estimation of plasma glu-
cose, serum cholesterol, serum triglycerides, glycated
heamoglobin (A1c), hexokinase, glucose-6-phosphatase
and fructose-1-6-biphophatase (Table 5). The following
pharmacological effects were observed:
Effect on glycemic control
The mean blood glucose level in rats fed on normal diet
(normal control wistar rats, group I) was almost invari-
able throughout the experimental study. In unison, the
blood glucose level of normal control rats treated with
Qurs Tabasheer kept on normal diet (group II) was close
to the normal control rats. On the contrary, the blood
glucose level of STZ- treated wistar rats (STZ-diabetic
control) was increased to a significant level (P < 0.01).
When STZ-induced diabetic rats (FBG ≥ 230 mg/dL)
was treated with Qurs Tabasheer with dose of 200 mg/
kg (group VI), lowering in blood glucose was observed
to maximum as compared to the dose of 50 mg/kg p.o
(group IV),100 mg/kg p.o (group V), 200 mg/kg p.o and
standard drug Glimpepiride (1 mg/kg p.o) respectively
(Figure 1).
Effect on the levels of plasma insulin
Plasma insulin levels of STZ-induced diabetic rats were
significantly lowered as compared to the normal control
(group I) and Qurs Tabasheer treated normal control
(group II) rats. Qurs Tabasheer boosts the level of
plasma insulin in dose dependent manner and exhibited
the maximum threshold at a dose of 200 mg/kg p.o (for
28 days) when compared to the other doses of 50,
Table 5 Biochemical parameters at the end of study


















1. Fasting plasma glucose (mg/dL) 84.64 ± 3.634 78.64 ± 3.091 301.1 ± 5.345 194.2 ± 2.873* 133.8 ± 4.149* 88.52 ± 3.923*** 101.1 ± 4.106
2 Fasting Plasma Insulin (μU/mL) 11.22 ± 0.2080 11.80 ± 0.3041 2.708 ± 0.2008 4.866 ± 0.3105 6.890 ± 0.1796* 9.674 ± 0.2214** 7.430 ± 0.2577
3. Glycated Heamoglobin (A1c) (%) 1.594 ± 0.07737 1.600 ± 0.08961 3.444 ± 0.2352 1.718 ± 0.09896 1.874 ± 0.09239** 2.594 ± 0.2068*** 1.878 ± 0.04271
4. Total Cholesterol (mg/dl) 77.98 ± 4.946 85.60 ± 3.832 166.8 ± 3.133 152.6 ± 3.320 133.9 ± 3.762* 118.9 ± 5.337** 164.2 ± 5.620
5. Triglycerides (mg/dl) 82.52 ± 5.211 77.54 ± 2.119 124.3 ± 3.229 118.9 ± 3.214 102.0 ± 1.360** 100.9 ± 3.313** 129.0 ± 3.316
6. Hexokinase (μg/mg of tissue) 148.4 ± 1.606 142.5 ± 1.888 102.7 ± 1.732 107.3 ± 1.875 128.2 ± 3.487** 137.6 ± 3.432*** 121.2 ± 1.511
7. Glucose-6-Phosphatase (unit/mg of tissue) 10.27 ± 0.1574 10.22 ± 0.3006 15.79 ± 0.6483 14.45 ± 0.5288 12.99 ± 0.5063* 10.06 ± 0.2851*** 15.08 ± 0.5064
8. Fructose-1-6-biphosphatase (unit/mg of
tissue)
30.30 ± 0.7938 30.04 ± 0.8185 51.19 ± 1.223 48.20 ± 1.272 38.19 ± 1.389* 34.67 ± 1.700** 41.02 ± 1.236
9. Weight Variation (g) 201.8 ± 4.664 208.0 ± 4.713 134.5 ± 3.681 137.2 ± 3.374 144.9 ± 4.532* 150.8 ± 2.453** 155.3 ± 2.409
The data are expressed in mean ± SEM) (n = number of animals in each group = 5). The comparisons were made by ANOVA followed by Dunnett’s test.
ns-non-significant; STZ-streptozotocin.
*P < 0.05 is considered as significant.
**P < 0.01 is considered as very significant.


























Figure 1 Effect of Qurs Tabasheer on glycemic control at different concentrations on normal and STZ induced diabetic rats, compared to
standard drug Glimepiride; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as non-significant (ns).
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Glimepiride (Figure 2).
Effect on the levels of glycated heamoglobin (A1c)
Glycated heamoglobin (A1c) of STZ-induced treated
diabetic rats was increased to a momentous level. Level
of A1c was normal in the wistar rats fed with normal
diet (group I) in conjunction with the normal control
rats received Qurs Tabasheer with dose of 200 mg/kg
(group II). When STZ-induced diabetic rats were treatedFigure 2 Effect of Qurs Tabasheer on level of plasma insulin at differe
compared to standard drug Glimepiride; values are mean ± SEM; n =
non-significant (ns).with Qurs Tabasheer with dose viz. (200 mg/kg), level of
glycated heamoglobin (A1c) was significantly reduced,
compared to the groups received 50 mg/kg p.o (group
IV), 100 mg/kg p.o (group V) 200 mg/kg p.o of Qurs
Tabasheer and 1 mg/kg p.o of Glimepiride correspond-
ingly (Figure 3).
Effect on the levels of total cholesterol
It is perceptible from figure 3 that serum cholesterol
levels of untreated diabetic rats was significantly highernt concentrations on normal and STZ induced diabetic rats,
6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as
Figure 3 Effect of Qurs Tabasheer on glycated heamoglobin (A1c) (%) at different concentrations on normal and STZ induced diabetic
rats, compared to standard drug Glimepiride; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as
non-significant (ns).
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control rats receiving Qurs Tabasheer (group II). Upon
administration of unani herbal formulation Qurs
Tabasheer (50 mg/kg p.o, 100 mg/kg p.o and 200 mg/kg
p.o for 28 days, group IV, V & VI) in the STZ-induced
diabetic rats the level of serum cholesterol lowered to a
considerable level with maximum effect seen in the
group administered with 200 mg/kg of Qurs Tabasheer.
While the group received only Glimepiride (1 mg/kg p.o
for 28 days) (group VII) shows no significant changes in
the serum cholesterol (Figure 4).Figure 4 Effect of Qurs Tabasheer on total cholesterol at different concen
standard drug Glimepiride; values are mean ± SEM; n = 6; *P < 0.05; **P <Effect on the levels of serum triglycerides
The administration of Qurs Tabasheer in normal control
rats shows a slight decrease in the serum triglyceride
level. On contrary, level of serum triglycerides signifi-
cantly increased in STZ-induced diabetic rats (group
III). Upon administration of different doses of Qurs
Tabasheer (50 mg/kg, 100 mg/kg & 200 mg/kg) the level
of serum triglycerides subordinate to a good extent. The
maximum lowering of serum triglycerides was appeared
in group received Qurs Tabasheer at a dose of 200 mg/
kg (Figure 5).trations on normal and STZ induced diabetic rats, compared to
0.01; ***P < 0.001; P > 0.05 is considered as non-significant (ns).
Figure 5 Effect of Qurs Tabasheer on serum triglycerides at different concentrations on normal and STZ induced diabetic rats,
compared to standard drug Glimepiride; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as
non-significant (ns).
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To evaluate the effect of Qurs Tabasheer on distressed hep-
atic activity, we administered Qurs Tabasheer to normal as
well as in STZ-induced diabetic rats. Hexokinase level
decreased in a considerable in STZ-treated diabetic rats.
Administration of Qurs Tabasheer in normal rats shows lit-
tle or no significant changes in the level of hepatic hexoki-
nase. STZ-induced diabetic rats received Qurs Tabasheer
shows exponential increase in the level of hepatic hexoki-
nase (Figure 5). Diabetic rats treated with Qurs Tabasheer
with a dose of 200 mg/kg p.o (for 28 days) showedFigure 6 Effect of Qurs Tabasheer on level of hexokinase at different
compared to standard drug Glimepiride; values are mean ± SEM; n =
non-significant (ns).maximum augmentation in the level of hexokinase as com-
pared to other groups received different doses of Qurs
Tabasheer. While the Group received Glimepiride (1 mg/kg
p.o) develop slight increase in the level of hepatic hexoki-
nase (group VII) (Figure 6).
Effect on the levels of glucose-6-phosphatase
It is evident from figure that upon administration of STZ to
wistar rats the level of glucose-6-phosphatase was declined
to a considerable level. Qurs Tabasheer when administered
to normal control rats shows little or no changes in theconcentrations on normal and STZ induced diabetic rats,
6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as
Figure 7 Effect of Qurs Tabasheer on level of glucose-6-phosphatase at different concentrations on normal and STZ induced diabetic
rats, compared to standard drug Glimepiride; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as
non-significant (ns).
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received Qurs Tabasheer with the dose of 200 mg/kg
(group VI) shows remarkable increase in the level of
glucose-6-phosphatase when weighed against the dose of
50 mg/kg p.o (group IV), 100 mg/kg p.o (group V) and
200 mg/kg p.o (group VI). STZ-induced diabetic rats’ admi-
nistered with Glimepiride (1 mg/kg) shows a trivial boost in
the level of glucose-6-phosphatase (Figure 7).
Effect on the levels of fructose-1-6-biphosphatase
STZ-induced diabetic rats develop high levels of Fruc-
tose-1-6-biphosphatase. Upon administration of Qurs
Tabasheer to normal control rats the level of Fructose-1-Figure 8 Effect of Qurs Tabasheer on level of fructose-1-6-biphospha
diabetic rats, compared to standard drug Glimepiride; values are mea
considered as non-significant (ns).6-biphosphatase does not change much. When STZ-
induced diabetic rats received Qurs Tabasheer, shows
significant decrease in the level of Fructose-1-6-
biphosphatase with the dose of 200 mg/kg (group VI).
Effect of 50 mg/kg p.o (group IV) and 100 mg/kg p.o
(group V) of Qurs Tabasheer was subordinate as com-
pared to 200 mg/kg p.o (Figure 8).
Effect on weight variation
Administration of Qurs Tabasheer demonstrates weight
gain in STZ-induced diabetic rats. Weight of STZ-
diabetic rats increases to a remarkable extent with dose
of 200 mg/kg p.o of Qurst Tabasheer as compared to thetase at different concentrations on normal and STZ induced
n ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is
Figure 9 Effect of Qurs Tabasheer on body weight at different concentrations on normal and STZ induced diabetic rats, compared to
standard drug Glimepiride; values are mean ± SEM; n = 6; *P < 0.05; **P < 0.01; ***P < 0.001; P > 0.05 is considered as non-significant (ns).
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and 1 mg/kg p.o of Glimpepiride (Figure 9).Histopathological studies
Animals were sacrificed with administration of overdose of
anesthetic ether. The liver and pancreas were immediately
expurgated. Liver and whole pancreas were removed and
washed with ice cold 0.9% sodium chloride solution. TheFigure 10 PN = Photomicrograph of section of normal pancreas (150
PQ = Photomicrograph of section of pancreas (150x) of normal rat adminis
and pancreatic acini. PST = Photomicrograph of section of pancreas of STZ
pancreatic acini with areas of fibrosis. PGL = Photomicrograph of section o
(150x), yellow arrows showing mild fibrosis of pancreatic acini. PQ 50 = Sec
(50 mg/kg p.o) for 28 days, (150x), yellow arrows showing mild fibrosis of p
PQ 100 = Photomicrograph of section of pancreas of diabetic Wistar rat tre
arrows showing very mild fibrosis of pancreatic acini. PQ 200 = Photomicro
Qurs Tabasheer (200 mg/kg p.o) for 28 days (150x), yellow arrows showingtissues were conserved in buffered 10% neutral formalin
and stored at −20°C until processed [21].
Histopathological studies on liver and pancreas of normal
and STZ-diabetic rats shows relative more degree of hepa-
toprotection and retardation of pancreatic degradation with
increasing dose of herbal medicine Qurs Tabasheer as com-
pared to the standard oral hypoglycemic Glimepiride. The
section of rat pancreas from normal control group exhibits
normal pancreatic acini (Figure 10 PN). STZ diabetic ratsx), showing normal lobules of pancreatic acini.
tered with 200 mg/kg/p.o of Qurs Tabasheer, showing normal lobules
treated diabetic Wistar rat, 150x, yellow arrows showing lobules of
f pancreas of diabetic rat treated with Glimepiride alone for 28 days,
tion of pancreas of diabetic Wistar rat treated with Qurs Tabasheer
ancreatic acini and normal islet of langerhans.
ated with Qurs Tabasheer (100 mg/kg p.o) for 28 days (150x), yellow
graph of section of pancreas of diabetic Wistar rat treated with with
normal pancreatic acini and islet of langerhans.
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langerhans of pancreas (Figure 10 PST). Normal control
rats treated with herbal medicine Qurs Tabasheer showed
no signs of degenerative changes in islet of langerhans and
in contrast shows normal acini and islets of langerhans
(Figure 10- PQ). Pancreatic sections of STZ diabetic rat
treated with different doses of Qurs Tabasheer viz 50
mg/kg p.o., 100 mg/kg p.o and 200 mg/kg p.o (Figure 10-
PQ50; Figure 10-PQ100; Figure 10-PQ200) showed a
marked improvement in the morphology of islet of langer-
hans and acini of pancreas with greatest improvement
being showed in the dose of 200 mg/kg p.o of Qurs
Tabasheer as compared to the standard drug Glimepiride
(Figure 10-PGL). While the section of rat liver of normal
control group showed normal lobular pattern with a cen-
trilobular vein and scorching irregular anastomosing
plates of hepatocytes with intervening sinusoids (Figure 11-
LN). Liver of normal rat treated with Qurs Tabasheer also
shows normal hepatocytes and sinusoids (Figure 11-LQ).
Sections of the diabetic rat liver cells shows accumulation
of droplets with distorted morphology of hepatocytes, cen-
trilobular vein and sinusoids (Figure 11-LS). The photo-
micrograph of STZ-diabetic rats treated with different
doses of Qurs Tabasheer viz 50 mg/kg p.o., 100 mg/kg p.o
and 200 mg/kg p.o (Figure 11-LQ 50; 11-LQ 100; 11-LQ-Figure 11 LN = Photomicrograph of section of liver of normal contro
centrilobular vein and scorching irregular anastomosing plates of hep
section of liver of normal control rat received 200 mg/kg p.o of Qurs Tabas
hepatocytes. LS = Photomicrograph of section of liver of STZ-diabetic rat (
distorted morphology of hepatocytes, centrilobular vein and sinusoids. LG
administered with 1 mg/kg p.o of Glimepiride, yellow arrow portrayed no s
LQ 50 = Photomicrograph of section of liver of STZ-diabetic rat (150 x) adm
docile hepatocytes and slightly distorted cetrilobular vein. LQ 100 = Photo
with 100 mg/kg p.o of Qurs Tabasheer, yellow arrow revealed slightly norm
of liver of STZ-diabetic rat (150 x) administered with 200 mg/kg p.o of Qur
distorted cetrilobular vein and hapatocytes.200) showed marked enhancement of morphology of
liver hepatocytes with normal sinusoids with the
greatest effect exhibited in the dose of 200 mg/kg/p.o
(Figure 11-LQ200) when compared to the standard
drug Glimepiride (Figure 11-LG).Discussion
The cytotoxic action of Streptozotocin (STZ) is
mediated by reactive oxygen species (ROS). Streptozoto-
cin (STZ) penetrates the β-cells via glucose transporter
(GLUT2) and causes alkylation of the DNA [14]. The al-
kylating activity of STZ is related to its nitrosourea moti-
ety [22]. According to West et al. [23] Streptozotocin
action in β-cells is being an adjunct to distinctive
amendment in blood insulin and glucose concentrations.
Two hours after STZ administration, hyperglycemia
develops with concomitant plunge in insulin level. After
six hours, hyperglycemia develops with high levels of in-
sulin. Finally, severe hyperglycemia develops with de-
crease in insulin levels [23].
In the present research exertion, the administration of
Qurs Tabasheer revealed the balanced decrease in the
blood glucose, serum cholesterol, serum triglycerides, &
fructose-1-6-biphosphatase while showed a significantl rat (150x), yellow arrows showing lobular pattern with a
atocytes with intervening sinusoids. LQ = Photomicrograph of
heer (150x), yellow arrows showing normal lobular pattern and
150 x) yellow arrow demonstrate accumulation of droplets with
= Photomicrograph of section of liver of STZ-diabetic rat (150 x)
igns of normal hepatocytes and normal lobular pattern.
inistered with 50 mg/kg p.o of Qurs Tabasheer, yellow arrow exhibits
micrograph of section of liver of STZ-diabetic rat (150 x) administered
al hepatocytes and sinusoids. LQ 200 = Photomicrograph of section
s Tabasheer, yellow arrow divulged the marked improvement in the
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6-phosphatase (Table 5).
Many scientists have reported that Portulaca oleracea,
Rosa damascene, Punica granatum, Bambusa arundina-
cea, and Lactuca sativa Linn. have noteworthy anti-
hyperglycemic and glucose tolerance effect in the experi-
mentally induced diabetic rats. The plausible mechanism
of action of Qurs Tabasheer could be unswerving with
the evocative effect of sulfonylureas which bolster the in-
sulin secretion by closure of the K+ -ATPase channels,
membrane depolarization and increase in Ca++ ions
influx.
In this perspective, various medicinal plants of Qurs
Tabasheer viz. Portulaca oleracea [8] Rosa damasceneI
[9], Punica granatum [24], Bambusa arundinacea, [11]
Lactuca sativa Linn [12] (ingredients of Qurs Tabash-
eer) have been pragmatic to show analogous effects.
Body weight of Qurs-Tabasheer administered STZ-
induced diabetic rats was significantly increased
(Table 5, Figure 9). This effect may be due to the com-
petence of Qurs Tabasheer to abridged hyperglycemia.
Administration of Qurs Tabasheer to STZ-induced dia-
betic rats decreases the plasma glucose level (Table 5,
Figure 1), perhaps due to the augmented quantity of in-
sulin in diabetic rats. Additionally, Qurs Tabasheer might
improve the utilization of glucose and crafts the adipose
tissues more sensitive towards the insulin by enhancing
the PPAR-γ dependent mRNA expression, to reduce the
case of insulin resistance. In this framework, other
researchers [25] have reported that Punica Granatum
flower extract (one of the ingredients of Qurs Tabasheer)
targets the PPAR-γ for plummeting insulin resistance.
Li et al., [26] described that Punica Granatum flower
(PGF) extract targets the PPAR-γ as one of the mech-
anism of targeting the type-II diabetes mellitus. It has
been recently researched that PGF may thwart the de-
crease in glucose metabolism in diabetic cardio-
myocytes by triggering the cardiac PPAR-γ [26].
Earlier researchers have observed that Portulaca olera-
cea extract showed marked decrease in the blood glu-
cose level and increased insulin concentration in alloxan
induced diabetic rats by closure of K+ ATP channels,
membrane depolarization and stimulation of Ca++ influx
[8]. Furthermore, many scientists have established the
efficacy of Bambusa arundinacea to curtail the hypergly-
cemia. Bambusa arundinacea may inhibit the cohort of
free radicals accountable for destruction of pancreatic β-
cell [14] and may thus prevent the hyperglycemia in dia-
betic rats.
Gholamhoseinian et al. [9] investigated that extract of
Rosa damascene flowers inhibits α –glucosidase (enzyme
that is responsible for carbohydrate digestion and eleva-
tion of fasting blood glucose) in diabetic rats to facilitate
the decrease in blood glucose levels.Consequently, the antihyperglycemic effect of Qurs
Tabasheer may be due to the synergistic effects of the Por-
tulaca oleracea, Rosa damascene, Punica granatum, Bam-
busa arundinacea, and Lactuca sativa Linn. The plausible
mechanism of action of the polyherbal formulation may ei-
ther be due to the activation of PPAR-γ receptor or
increased insulin secretion from pancreatic β-cells due to
closure of K+ATP channels or may be attributable to free
radical scavenging property to shield β- cell from destruc-
tion or perhaps as a consequence of inhibition of α – glu-
cosidase enzyme in diabetic rats. As a result, it could be
possible the mechanism of action of Qurs Tabasheer may
be the amalgamation of all the probable mechanism
described.
The enhanced level of glycated heamoglobin (A1c) in
STZ-induced diabetic rats is primarily due to the exces-
sive production of glucose in the blood which further
reacts with blood heamoglobin to construct glycated
heamoglobin [27]. Qurs Tabasheer lowers the glycated
heamoglobin (A1c) in STZ-induced diabetic rats (Table 5,
Figure 3). The plausible cause of reduced glycated hea-
moglobin is the diminution of blood glucose level.
In consequence, we have reported in our present re-
search that Qurs Tabasheer also amends the imperative
glucose metabolizing enzymes in liver (Table 5). Hepatic
hexokinase is a prime enzyme that converts glucose into
glucose-6-phosphate. Decreased level of hexokinase STZ-
induced diabetic rats can be accountable for diminished
glycolysis which results in decreased utilization of glucose
for energy production [28]. The Qurs Tabasheer adminis-
tered STZ-induced diabetic rats significantly amplify the
level of hepatic hexokinase. (Table 5, Figure 6). Increased
level of hepatic hexokinase cause increased glycolysis and
consequently improves the utilization of glucose. Another
vital enzyme of liver that regulates the glucose metaboliz-
ing enzyme is glucose-6-phosphatase. Other scientists
depicted the enhanced activity of gluconeogenetic enzyme
in diabetic states [29,30]. Diabetes increases the activity of
glucose-6-phosphatase [31]. The increased activity of
glucose-6-phosphatase was depicted in the STZ-induced
diabetes mellitus rats (Table 5). Raised amount of Admin-
istration of glucose-6-phosphatase enhances the produc-
tion of fats from carbohydrates [32]. Qurs Tabasheer
significantly reduces the level of glucose-6-phosphatase
(Figure 7). Activity of Fructose-1-6-biphosphate was con-
siderably raised in STZ-induced diabetic rats (Table 5).
Qurs Tabasheer lowers the activity of this gluconeogenetic
enzyme to a considerable extent (Figure 8).
Plasma insulin levels in STZ-induced diabetic rats were
diminished significantly (Table 5) Plasma insulin levels
were found to be increased a substantial level in Qurs
Tabasheer treated diabetic rats (Figure 2). This increase
may be a corollary to the decreased level of the glucose-6-
phosphatase and fructose-1-6-biphosphatase.
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induced diabetic rats, insulin paucity is coupled with
hypercholesterolemia and hypertriglyceridemia. As HMG
Co-A reductase enzyme is accountable for the synthesis of
cholesterol and insulin has an inhibitory effect on HMG-
Co-A reductase. It is obvious that deficiency of insulin will
improve the generation of cholesterol and triglycerides
[33]. Administration of Qurs Tabasheer to STZ-induced
diabetic rats decreased the level of total cholesterol and
triglycerides (Table 5, Figures 4 &5). As the levels insulin
has been increased in Qurs Tabasheer treated diabetic
rats, which may be the outcome of decreased cholesterol
and triglycerides level.Conclusion
It is worth mentioning that Qurs Tabasheer efficiently
trims down the levels of blood glucose, total cholesterol,
triglycerides and gluconeogenetic enzymes without pro-
ducing any adverse effect viz. hypoglycemia. The results
from the present study and histological analysis indicate
the administration of Qurs Tabasheer, has significantly
protective effects against STZ-induced diabetic state.
This significant protection of Qurs Tabasheer may be
due to synergistic effect of the constituents of the drug.
The antidiabetic effect of Qurs Tabasheer was more ef-
fectual than Glimepiride. These finding strengthen the
observation that naturally occurring compounds of plant
origin are much more effective in controlling diabetes
than synthetic oral hypoglycemics. Further, biochemical
and pharmacological investigations are in progress in
our laboratory to explicate the mechanism of action of
the Qurs Tabasheer.
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